796 filings
Page 2 of 40
8-K
BCDA
BioCardia Inc.
31 Jan 24
BioCardia Announces Two Scientific Abstracts Have Been Accepted at the 2024 Technology and Heart Failure Therapeutics Conference
7:00am
4
BCDA
BioCardia Inc.
22 Jan 24
BioCardia / PHILLIP MD ET AL FROST ownership change
8:38pm
8-K
BCDA
BioCardia Inc.
3 Jan 24
Business Development Update for Shareholders
7:00am
8-K
BCDA
BioCardia Inc.
19 Dec 23
Other Events
7:00am
8-K
BCDA
BioCardia Inc.
18 Dec 23
BioCardia Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical and Medical Device Agency Consultation Minutes
7:00am
8-K
BCDA
BioCardia Inc.
6 Dec 23
Other Events
6:05am
424B5
BCDA
BioCardia Inc.
6 Dec 23
Prospectus supplement for primary offering
6:03am
EFFECT
BCDA
BioCardia Inc.
6 Dec 23
Notice of effectiveness
12:15am
8-K/A
BCDA
BioCardia Inc.
5 Dec 23
Submission of Matters to a Vote of Security Holders
4:11pm
8-K
BCDA
BioCardia Inc.
5 Dec 23
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:05pm
CORRESP
BCDA
BioCardia Inc.
1 Dec 23
Correspondence with SEC
12:00am
8-K
BCDA
BioCardia Inc.
29 Nov 23
Other Events
7:00am
424B5
BCDA
BioCardia Inc.
17 Nov 23
Prospectus supplement for primary offering
5:25pm
8-K
BCDA
BioCardia Inc.
16 Nov 23
Securities Purchase Agreement
5:15pm
CORRESP
BCDA
BioCardia Inc.
15 Nov 23
Correspondence with SEC
12:00am
8-K
BCDA
BioCardia Inc.
14 Nov 23
BioCardia Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure
12:00am
CORRESP
BCDA
BioCardia Inc.
14 Nov 23
Correspondence with SEC
12:00am
8-K
BCDA
BioCardia Inc.
8 Nov 23
Biocardia Reports Third Quarter 2023 Business Highlights and Financial Results
4:08pm
10-Q
2023 Q3
BCDA
BioCardia Inc.
Quarterly report
8 Nov 23
4:06pm
UPLOAD
BCDA
BioCardia Inc.
24 Oct 23
Letter from SEC
12:00am